News
Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, ...
Hosted on MSN3mon
Siemens Agrees to Buy Dotmatics for $5.1 Billion, Expanding AI Portfolio to Life Sciences - MSNSiemens has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development cycles and help make breakthroughs in the life ...
MUNICH, April 2, 2025 /PRNewswire/ -- Siemens AG announces that it has signed an agreement to acquire Dotmatics, a leading provider of Life Sciences R&D software based in Boston, for $5.1 billion ...
Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners to strengthen its Life Sciences portfolio.
Siemens AG has agreed to acquire Dotmatics for $5.1 billion as part of a push to provide more artificial intelligence software to life sciences companies. The German company announced the deal for ...
Siemens SIE-0.21%decrease; red down pointing triangle has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development ...
Acquisition of Dotmatics, a leader in Life Sciences R&D software for $5.1 billionExpands Siemens' market-leading position in industrial software by extending AI-powered Product Lifecycle ...
MUNICH, April 2, 2025 /PRNewswire/ -- Siemens AG announces that it has signed an agreement to acquire Dotmatics, a leading provider of Life Sciences R&D software based in Boston, for $5.1 billion ...
Acquisition of Dotmatics, a leader in Life Sciences R&D software for $5.1 billionExpands Siemens' market-leading position in industrial software by extending AI-powered Product Lifecycle ...
Siemens AG announces that it has signed an agreement to acquire Dotmatics, a leading provider of Life Sciences R&D software based in Boston, for $5.1 billion from Insight Partners. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results